{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:28:06Z","timestamp":1786415286972,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010658","name":"St Paul's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cjco.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:49:18Z","timestamp":1774658958000},"page":"1109-1118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery: A Pilot Randomized Controlled Trial"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8720-5794","authenticated-orcid":false,"given":"Erica H.Z.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Atherstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Gwozd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.03.011_bib1","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2026.03.011_bib2","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.03.011_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.03.011_bib4","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14796678.2025.2484119","article-title":"Real-world evidence comparing oral anticoagulants for NVAF in Europe: a systematic review and network meta-analysis","volume":"21","author":"Cichewicz","year":"2025","journal-title":"Future Cardiol"},{"key":"10.1016\/j.cjco.2026.03.011_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/hematolrep17050054","article-title":"Vitamin K antagonists (VKAs) and novel oral anticoagulants (NOACs) safety comparison based on data from Eudravigilance database","volume":"17","author":"Olimpieri","year":"2025","journal-title":"Hematol Rep"},{"key":"10.1016\/j.cjco.2026.03.011_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436,864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2026.03.011_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jval.2024.11.012","article-title":"Prescription medication use and expenditure for atrial fibrillation in the United States","volume":"28","author":"Thyagaturu","year":"2025","journal-title":"Value Health"},{"key":"10.1016\/j.cjco.2026.03.011_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/icvts\/ivx011","article-title":"Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery","volume":"24","author":"Khan","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.carrev.2019.04.002","article-title":"Hemorrhagic cardiac tamponade associated with apixaban: a case report and systematic review of literature","volume":"20","author":"Asad","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cjco.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0003-4975(02)03837-7","article-title":"Postoperative cardiac tamponade in the modern surgical era","volume":"74","author":"Kuvin","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","article-title":"2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery","volume":"32","author":"Boer","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cjco.2026.03.011_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1089253214532375","article-title":"Pathophysiology of cardiopulmonary bypass: current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction","volume":"18","author":"Esper","year":"2014","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cjco.2026.03.011_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/europace\/euw208","article-title":"Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey","volume":"18","author":"Vranckx","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2026.03.011_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jtcvs.2019.09.064","article-title":"Non\u2013vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing","volume":"160","author":"Beller","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2Part A","key":"10.1016\/j.cjco.2026.03.011_bib16","first-page":"65","article-title":"Direct oral anticoagulant use early after cardiac surgery: a retrospective cohort study","volume":"6","author":"Wu","year":"2023","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2026.03.011_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jtcvs.2023.03.004","article-title":"Direct oral anticoagulants for atrial fibrillation in early postoperative valve repair or bioprosthetic replacement","volume":"168","author":"Moser","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ans.70045","article-title":"Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation","volume":"95","author":"Chang","year":"2025","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib19","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2026.03.011_bib20","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2026.03.011_bib21","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2026.03.011_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.03.011_bib23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.03.011_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-10-1","article-title":"A tutorial on pilot studies: the what, why and how","volume":"10","author":"Thabane","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cjco.2026.03.011_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2026.03.011_bib26","first-page":"169","article-title":"Half-dose direct oral anticoagulation versus warfarin for atrial fibrillation following cardiac surgery","volume":"65","author":"Hashim","year":"2024","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.cjco.2026.03.011_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa2507532","article-title":"Aspirin in patients with chronic coronary syndrome receiving oral anticoagulation","volume":"393","author":"Lemesle","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2026.03.011_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13019-025-03378-x","article-title":"Clinical management after surgical left atrial appendage exclusion","volume":"20","author":"Bhave","year":"2025","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.122.060315","article-title":"Oral anticoagulation use and left atrial appendage occlusion in LAAOS III","volume":"148","author":"Connolly","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1074248420929483","article-title":"Comparison of anticoagulants for postoperative atrial fibrillation after coronary artery bypass grafting: a pilot study","volume":"25","author":"Chapin","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cjco.2026.03.011_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12872-024-04064-x","article-title":"Early anti-coagulation therapy in new-onset atrial fibrillation after coronary artery bypass grafting: a randomized trial pilot study","volume":"24","author":"Ghavami","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjco.2026.03.011_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/SLA.0000000000006853","article-title":"Randomized controlled: trial of new oral anticoagulants versus warfarin for postcardiac surgery atrial fibrillation: the NEW-AF trial","volume":"282","author":"Moonsamy","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2021.01.127","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial","volume":"165","author":"Shim","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjco.2026.03.011_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.015108","article-title":"Efficacy and safety of edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: a randomized clinical trial","volume":"18","author":"Izumi","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjco.2026.03.011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133023","article-title":"Design and rationale of the multicenter randomized clinical trial (REVERSE): efficacy and safety of rivaroxaban in the early postoperative period for patients with bioprosthetic valve replacement or valve repair","volume":"425","author":"Wang","year":"2025","journal-title":"Int J Cardiol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:35:12Z","timestamp":1786412112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X26001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589790X26001046"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.03.011","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery: A Pilot Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}